The DOI matches its Crossref record; 256 of the 256 references it cites were found in a registry or an index.
Handling uncertainty when performing economic evaluation of healthcare interventions.
Open accessAbstract
NHS R&D HTA ProgrammeT he overall aim of the NHS R&D Health Technology Assessment (HTA) programme is to ensure that high-quality research information on the costs, effectiveness and broader impact of health technologies is produced in the most efficient way for those who use, manage and work in the NHS.Research is undertaken in those areas where the evidence will lead to the greatest benefits to patients, either through improved patient outcomes or the most efficient use of NHS resources.The Standing Group on Health Technology advises on national priorities for health technology assessment.Six advisory panels assist the Standing Group in identifying and prioritising projects.These priorities are then considered by the HTA Commissioning Board supported by the National Coordinating Centre for HTA (NCCHTA).This report is one of a series covering acute care, diagnostics and imaging, methodology, pharmaceuticals, population screening, and primary and community care.It was identified as a priority by the Methodology Panel and funded as project number 93/48/07.The views expressed in this publication are those of the authors and not necessarily those of the Standing Group, the Commissioning Board, the Panel members or the Department of Health.The editors wish to emphasise that funding and publication of this research by the NHS should not be taken as implicit support for the recommendations for policy contained herein.In particular, policy options in the area of screening will be considered by the National Screening Committee.This Committee, chaired by the Chief Medical Officer, will take into account the views expressed here, further available evidence and other relevant considerations.Reviews in Health Technology Assessment are termed 'systematic' when the account of the search, appraisal and synthesis methods (to minimise biases and random errors) would, in theory, permit the replication of the review by others.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–256 of 256
Lindholm, L. H., Rosén, M., Weinehall, L., & Asplund, K. (1996) · Journal of Epidemiology & Community Health · doi:10.1136/jech.50.2.190 · Cited by 45
Estimating the cost effectiveness of total androgen blockade with flutamide in M1 prostate cancer
Hillner, B. E., McLeod, D. G., Crawford, E. D., & Bennett, C. L. (1995) · Urology · doi:10.1016/s0090-4295(99)80055-7 · Cited by 44
Screening Surgeons for HIV Infection: A Cost-effectiveness Analysis
Owens, D. K., Harris, R. A., Scott, P. M., & Nease, R. F. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-9-199505010-00001 · Cited by 44
Cost-Effectiveness of Rescreening Conventionally Prepared Cervical Smears by PAPNET Testing
Schechter, C. B. (1996) · Acta Cytologica · doi:10.1159/000334021 · Cited by 42
The Negative Side of Cost-effectiveness Analysis
Mullahy, J. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540480031025 · Cited by 40
The cost effectiveness of lipid lowering in Swedish primary health care
Johannesson, M., Borgqúist, L., Jönsson, B., & Lindholm, L. H. (1996) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1996.491830000.x · Cited by 40
Cost-effectiveness analysis for evaluation of screening programs: hereditary hemochromatosis
Buffone, G. J., & Beck, J. R. (1994) · Clinical Chemistry · doi:10.1093/clinchem/40.8.1631 · Cited by 40
Costs of intrapartum care in a midwife-managed delivery unit and a consultant-led labour ward
Hundley, V. A., Donaldson, C., Lang, G. D., Cruickshank, F. M., Glazener, C. M. A., Milne, J. M., & Mollison, J. (1995) · Midwifery · doi:10.1016/0266-6138(95)90024-1 · Cited by 40
The cost effectiveness of three programs to increase use of bicycle helmets among children
Hatziandreu, E. J., Sacks, J. J., Brown, R., Taylor, W. R., Rosenberg, M. L., & Graham, J. D. (1997) · Journal of Safety Research · doi:10.1016/s0022-4375(96)00036-9 · Cited by 39
Screening blood donors for human immunodeficiency virus antibody: cost-benefit analysis.
Eisenstaedt, R. S., & Getzen, T. (1988) · American Journal of Public Health · doi:10.2105/ajph.78.4.450 · Cited by 39
Impact of Day Care on Dementia Patients–Costs, Well-being and Relatives′ Views
Wimo, A. B., WALLIN, J.-O., Lundgren, K., Rönnbäck, E., KENNETH, A., Mattsson, B., & Krakau, I. (1990) · Family Practice · doi:10.1093/fampra/7.4.279 · Cited by 39
Cost Analysis of Aggressive Breast Cancer Screening
Moskowilt, M., & Fox, S. H. (1979) · Radiology · doi:10.1148/130.1.253 · Cited by 39
Briggs, A. H., & Fenn, P. (1997) · Health Economics · Cited by 36
Economics of a reduction in smoking: case study from Heartbeat Wales.
Phillips, C. J., & Prowle, M. (1993) · Journal of Epidemiology & Community Health · doi:10.1136/jech.47.3.215 · Cited by 36
Cantor, J. C., Morisky, D. E., Green, L. W., Levine, D. M., & Salkever, D. S. (1985) · Preventive Medicine · doi:10.1016/0091-7435(85)90071-4 · Cited by 36
Health-related quality of life measurement for evaluation research and policy analysis.
Bush, J. W. (1982) · Health Psychology · doi:10.1037//0278-6133.1.1.61 · Cited by 36
Reporting Cost-Effectiveness Studies and Results
Siegel, J. E., Weinstein, M. C., & Torrance, G. W. (1996) · doi:10.1093/oso/9780195108248.003.0009 · Cited by 36
Case-Finding for Unsuspected Thyroid Disease: Costs and Health Benefits
Nolan, J. P., Tarsa, N. J., & DiBenedetto, G. (1985) · American Journal of Clinical Pathology · doi:10.1093/ajcp/83.3.346 · Cited by 35
The cost‐effectiveness of liver biopsy in rheumatoid arthritis patients treated with methotrexate
Bergquist, S. R., Felson, D. T., Prashker, M. J., et al. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380306 · Cited by 35
The cost-utility of diet and exercise interventions in non-insulin-dependent diabetes mellitus
Kaplan, R. M., ATKINS, C. J., & Wilson, D. K. (1987) · Health Promotion International · doi:10.1093/heapro/2.4.331 · Cited by 33
Johannesson, M., Agewall, S., Hartford, M., Hedner, T., & Fagerberg, B. (1995) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1995.tb01135.x · Cited by 32
An economic evaluation of universal vaccination against hepatitis B virus
Fenn, P., Gray, A., & McGuire, A. J. (1996) · Journal of Infection · doi:10.1016/s0163-4453(96)80019-3 · Cited by 32
Cost‐effectiveness analysis of day care for patients with dementia disorders
Wimo, A. B., Mattsson, B., Krakau, I., Eriksson, T., & Nelvig, A. (1994) · Health Economics · doi:10.1002/hec.4730030607 · Cited by 31
Buxton, M. J., & O’Brien, B. J. (1992) · PubMed · Cited by 31
Confidence Intervals for Cost - Effectiveness Ratios
Gardiner, J. C., Hogan, A. J., Holmes-Rovner, M. M., Rovner, D., Griffith, L. S. C., & Kupersmith, J. (1995) · Medical Decision Making · doi:10.1177/0272989x9501500308 · Cited by 30
Cost-Effectiveness of Detecting and Treating Diabetic Retinopathy
Javitt, J. C., & Aiello, L. P. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-11-199612010-00020 · Cited by 30
Butler, J. R. G., & FLETCHER, P. J. (1996) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1996.tb02912.x · Cited by 29
Anton, S. F., & Revicki, D. A. (1995) · PubMed · Cited by 29
Making Decisions About Antithrombotic Therapy in Heart Disease
Eckman, M. H., Levine, H. J., & Pauker, S. G. (1995) · CHEST Journal · doi:10.1378/chest.108.4_supplement.457s · Cited by 29
Cost-effectiveness of primary tetanus vaccination among elderly Canadians.
Hutchison, B. G., & Stoddart, G. L. (1988) · PubMed · Cited by 27
A cost-effectiveness analysis of hepatitis B vaccine in predialysis patients.
Oddone, E. Z., Cowper, P. A., Hamilton, J. D., & Feussner, J. R. (1993) · Europe PMC (PubMed Central) · Cited by 26
The Costs and Benefits of a Screening Program to Detect Dementia in Older Drivers
Retchin, S. M., & Hillner, B. E. (1994) · Medical Decision Making · doi:10.1177/0272989x9401400402 · Cited by 25
Lee, T. H., Fukui, T., Weinstein, M. C., Tosteson, A. N. A., & Goldman, L. (1988) · Medical Decision Making · doi:10.1177/0272989x8800800408 · Cited by 25
Does the breast cancer dollar make sense?
Epstein, R. J. (1992) · European Journal of Cancer · doi:10.1016/s0959-8049(05)80084-x · Cited by 24
Assessing the benefits of transplant services.
Michel, B., van Hout, B., & Bonsel, G. (1994) · Bailliere's Clinical Gastroenterology · doi:10.1016/0950-3528(94)90028-0 · Cited by 23
Mays, N. (1991) · Social Science & Medicine · doi:10.1016/0277-9536(91)90201-m · Cited by 23
Stevens, R. D., Bingley, L. J., Boger, M., El-Wanni, J., & Kaston, J. (1984) · Social Science & Medicine · doi:10.1016/0277-9536(84)90103-5 · Cited by 22
Jonghe, E. D., Murray, C. J. L., Chum, H. J., Nyangulu, D. S., Salomão, A. L. S. J., & Styblo, K. (1994) · The International Journal of Health Planning and Management · doi:10.1002/hpm.4740090204 · Cited by 22
Cost-effectiveness of Clozapine Monitoring After the First 6 Months
Zhang, M. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830100104013 · Cited by 21
Mullahy, J. (1996) · PubMed · Cited by 21
Cost-effectiveness of intravenous thrombolytic drugs for acute myocardial infarction.
Naylor, C. D., Bronskill, S. E., & Goel, V. (1993) · PubMed · Cited by 21
Handling Uncertainty in the Results of Economic EvaluationPreprint
Briggs, A. H. (1995) · RePEc: Research Papers in Economics · Cited by 19
The Women's Health Trial as an Investment
Urban, N. D., & Baker, M. S. (1989) · Medical Decision Making · doi:10.1177/0272989x8900900111 · Cited by 18
Rutten, F., Ploeg, R. J., McDonnell, J., & COHEN, B. (1993) · Transplantation · doi:10.1097/00007890-199310000-00015 · Cited by 18
Implications of alternative strategies to diagnose coronary artery disease.
Stason, W., & Hv, F. (1982) · PubMed · Cited by 18
Malcolm, L. A., Kawachi, I. I., Jackson, R., & Bonita, R. (1988) · PubMed · Cited by 18
Buxton, M. J., Dubois, D. J., Turner, R. R., Sculpher, M. J., Robinson, P. A., & Searcy, C. (1991) · Journal of Infection · doi:10.1016/0163-4453(91)93975-i · Cited by 17
INDIRECT COSTS : THE CONSEQUENCE OF PRODUCTION LOSS OR INCREASED COSTS OF PRODUCTION
Koopmanschap, M. A. (2016) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 17
Floch, J. P. L., Charles, M.-A. A., Philippon, C., & Perlemuter, L. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb00285.x · Cited by 15
A Cost-Utility Analysis of Preoperative Total Parenteral Nutrition
Goel, V., & Detsky, A. S. (1989) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300006413 · Cited by 15
The Reliability of Cost-Utility Estimates in Cost-Per-QALY League Tables
Petrou, S., Malek, M., & Davey, P. G. (1993) · PharmacoEconomics · doi:10.2165/00019053-199303050-00002 · Cited by 14
Johannesson, M. (1996) · PubMed · Cited by 14
(1995) · New England Journal of Medicine · doi:10.1056/nejm199507273330424 · Cited by 12
A Cost-Effectiveness Analysis of Screening for Hepatitis B Surface Antigen in India
McNeil, B. J., Dudley, R. A., Hoop, B., Metz, C., Thompson, M., & Adelstein, S. J. (1981) · Medical Decision Making · doi:10.1177/0272989x8100100405 · Cited by 8
Cost-Effectiveness Analysis of Organ Transplantation
Scherstén, T., Brynger, H. O. A., Karlberg, I. H., & Jonsson, E. (1986) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300002622 · Cited by 7
Health and economic implications of a work-site smoking-cessation program: A simulation analysis
Warner, K. E., Smith, R., Smith, D., & Fries, B. E. (1997) · Excerpta medica. Section 35, Occupational health and industrial medicine · Cited by 6
Cited by
Bayesian Approaches to Clinical Trials and Health‐Care Evaluation
Spiegelhalter, D. J., Abrams, K. R., & Myles, J. P. (2003) · Wiley eBooks · doi:10.1002/0470092602 · Cited by 1,673
Representing uncertainty: the role of cost‐effectiveness acceptability curves
Fenwick, E., Claxton, K., & Sculpher, M. (2001) · Health Economics · doi:10.1002/hec.635 · Cited by 1,110
Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questions
Fenwick, E., O'Brien, B. J., & Briggs, A. (2004) · Health Economics · doi:10.1002/hec.903 · Cited by 943
Ramsey, S. D., Willke, R. J., Glick, H., Reed, S. D., Augustovski, F., Jonsson, B., Briggs, A., & Sullivan, S. D. (2015) · Value in Health · doi:10.1016/j.jval.2015.02.001 · Cited by 811
Self-citationHandling Uncertainty in Cost-Effectiveness Models
Briggs, A. H. (2000) · PharmacoEconomics · doi:10.2165/00019053-200017050-00006 · Cited by 807
Metadata
- Authors
- Briggs, & Gray
- Venue
- Health Technology Assessment
- Published
- 1999
- Volume
- 3
- Issue
- 2
- Pages
- 1-134
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W1571272128
- Cited by
- 387
- References
- 256
- FWCI
- 51.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.